GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2011 (Vol. 31, No. 18)

Open Optogenetics

URL:www.openoptogenetics.org
  • Up-to-date newsfeed and blog
  • Some glitches with navigation menus

When it comes to probing neural circuitry, researchers have certainly “seen the light.” In just a matter of years, optogenetics (involving the use of genetically encoded, light-activatable ion channels) has become a major experimental approach in neuroscience. This rapid expansion has created a need for shared resources among members of the neuroscience community to discuss various technical, experimental, and theoretical aspects of this technology. Enter OpenOptogenetics.org, which fills that precise void. With a goal of “promoting, facilitating, and democratizing the use of optogenetic approaches in biological research,” OpenOptogenetics.org offers user-provided information related to optogenetic tools, gene expression, and hardware. Additionally, the website provides a list of laboratories contributing to the site, as well as a limited number of links to other optogenetics websites. Finally, fitting for a website promoting communication among researchers, one of the strengths of this site is the blog. In all, this is a great open resource for optogenetics researchers.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?